Practice Management

Robot dermatologists aren’t yet seeing patients for routine care, but artificial intelligence (AI) and other technology tools are growing in popularity throughout the industry. Learn more about how these advances in technology are impacting practices.

Artificial intelligence (AI) tools are steadily growing in popularity throughout medicine, particularly in dermatology. But does AI pose a threat to dermatologists? Find out in this article.

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

What exactly is digital health? Dr. Steve Xu tackles this question in this month's Innovation column.

In this article, we take a look at the future of dermatology, including the rise of medical devices and drug costs.

Asana BioSciences announced that the U.S. Food and Drug Administration granted fast-track designation for the investigational ASN002, an oral treatment for moderate-to-severe atopic dermatitis. Learn more in this article.

Sandoz, a division of Novartis, announced that the U.S. Food and Drug Administration approved its biosimilar, adalimumabadaz (Hyrimoz, Novartis AG). 

The cost of clinical trials to get a dermatology drug to market may cost as much as $25 million, which is slightly above a median of $19 million, according to the latest research.

The National Psoriasis Foundation and the National Eczema Association have awarded Procter & Gamble’s Tide Free and Gentle Liquid Laundry Detergent and Tide PODS Free and Gentle Laundry Detergent a “Seal of Recognition” and “Seal of Acceptance” for people with eczema or sensitive skin.

In this article, Dr. Ronald G. Wheeland offers his point of view on how to define success in dermatology.

European Union regulation on data protecion has put pressure on U.S. legislators and regulators to heighten protections within our own borders, experts say. The ramifications for healthcare organizations, both abroad and in the United States, are significant. Here’s what you need to know.

The use of cloudbased platforms to send, receive and store patient data in teledermatology adds security risks.

Crown Laboratories has acquired Bellus Medical, allowing the firm to secure a variety of noninvasive aesthetic products, according to a company news release.

Almirall has closed on an agreement to acquire Allergan’s medical dermatology unit in the United States for $550 million.

In this month's Innovation column, Steve Xu, M.D. and Morgan Nguyen discuss how to incorporate innovation into medical societies.

The U.S. Food and Drug Administration has approved clearance for a new acne treatment that selectively targets sebaceous glands, according to a news release.

Proscia Inc., a digital technology company specializing in the development of artificial intelligence applications and software for digital pathology, recently secured $8.3 million in an initial round of financing.

In this month's Innovation Column, Drs. Steve Xu and William Ju discuss the need for entrepreneurship education in medical school and residency training.

Studies indicate physicians are fried, but a new review says it’s not as bad as it sounds.

Dermatologists who sell cosmeceutical products in their offices have options. Among the popular choices: They can sell already branded lines or brand their own skincare, hair, nail and other products.

Dermatologists can use online patient reviews as a tool to educate patients about minimally-invasive fat reduction procedures, according to a new study.

AIVITA Biomedical, a biotech firm that focuses on regenerative medicines such as stem cell applications, recently named two new members to its senior management team.

Two dermatology practices join forces to deliver excellent treatment options to patients in El Paso, Texas.

As more dermatologists implement EHR systems, many are wondering if EHR adoption will increase or decrease their medical legal liability. Dr. David Goldberg provides his insight in this month's legal column.

Two dermatology firms combine to improve their medical and cosmetic dermatology services, existing treatments and procedures.

Kleresca's new biophotonic technology received CE mark of approval, which will allow it to expand in the U.S., Canada, Australia and throughout Europe.

Developing doctor-patient relationships are key to avoiding oversimplification of characteristics like race and gender, which can result in stereotyping and medical mismanagement.

Pennsylvania Dermatology Partners tells its story of technological support and success.

A new Centers for Medicaid and Medicare Services plan for payment for evaluation and management services (E/M) has been proposed and CMS is currently accepting comments through 5 p.m., Sept. 10. The new rules would apply to all E/M services delivered after Jan. 1, 2019.